MedTrace Logo

Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary Hypertension

NCT07648524 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-06-15

No results posted yet for this study

Summary

This study aims to investigate the effect of cardiopulmonary rehabilitation on cardiorespiratory parameters and functional capacity in patients with pulmonary hypertension.

Conditions

  • Pulmonary Hypertension Due to Lung Disease (Disorder)

Interventions

BEHAVIORAL

cardiopulmonary rehabilitation in the form of moderate-intensity interval aerobic training

Training will be conducted on a treadmill three times weekly for 12 weeks. Exercise intensity will progress from 30-40% to 60-70% of target heart rate. Each session will last 30 minutes and include warm-up and cool-down periods.

DEVICE

Inspiratory Muscle Training

inspiratory muscle training will be performed using a Threshold Inspiratory Muscle Trainer (Philips Respironics). Training intensity will correspond to moderate-to-severe effort (3-5 on the Modified Borg Scale).

OTHER

Medical treatment

medication

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • NESREEN GHAREEB MOHAMED EL-NAHAS, Prof PT · faculty of P.T. Cairo University

  • HEBA AHMED ALI ABDEEN, Prof · faculty of P.T. Cairo University

  • HEND ABD EL-MONAEM ABD EL-MONAEM, Lecturer of physical therapy · faculty of P.T. Cairo University

  • REEM IBRAHIM EL KORASHY, prof of pulmonology · Cairo University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-13
Primary Completion
2026-09-13
Completion
2026-09-13

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07648524 on ClinicalTrials.gov